Page last updated: 2024-08-21

methylthioinosine and 6-aminonicotinamide

methylthioinosine has been researched along with 6-aminonicotinamide in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's8 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colofiore, JR; Koutcher, JA; Martin, DS; Nord, LD; Stolfi, RL1
Martin, DS1
Colofiore, JR; Martin, DS; Nord, LD; Sternberg, S; Stolfi, RL1
Colofiore, JR; Martin, DS; Nord, LD; Stolfi, RL3
Ballon, D; Koutcher, JA; Mahmood, U; Martin, DS; Matei, C; Street, JC1
Alfieri, AA; Ballon, D; Koutcher, JA; Martin, DS; Matei, C; Stolfi, RL; Tsai, JC1
Alfieri, AA; Koutcher, JA; Martin, DS; Matei, C; Thaler, H1
Gao, S; Hu, J; Liang, Z; Wu, X1

Other Studies

10 other study(ies) available for methylthioinosine and 6-aminonicotinamide

ArticleYear
Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination.
    Cancer research, 1992, Aug-01, Volume: 52, Issue:15

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Orotic Acid; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate

1992
Cancer chemotherapy: past is prologue.
    The Mount Sinai journal of medicine, New York, 1985, Volume: 52, Issue:6

    Topics: 6-Aminonicotinamide; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Humans; Male; Mammary Neoplasms, Experimental; Methotrexate; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid

1985
Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed.
    Cancer investigation, 1994, Volume: 12, Issue:3

    Topics: 6-Aminonicotinamide; Animals; Apoptosis; Aspartic Acid; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Energy Metabolism; Mammary Neoplasms, Experimental; Methylthioinosine; Phosphonoacetic Acid

1994
Biochemical modulation of tumor cell energy. IV. Evidence for the contribution of adenosine triphosphate (ATP) depletion to chemotherapeutically-induced tumor regression.
    Biochemical pharmacology, 1995, Nov-27, Volume: 50, Issue:11

    Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartic Acid; Doxorubicin; Mammary Neoplasms, Animal; Methylthioinosine; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Phosphonoacetic Acid; Time Factors

1995
Correlation of retention of tumor methylmercaptopurine riboside-5'-phosphate with effectiveness in CD8F1 murine mammary tumor regression.
    Biochemical pharmacology, 1996, Mar-08, Volume: 51, Issue:5

    Topics: 6-Aminonicotinamide; Adenosine Kinase; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid

1996
In vivo detection by 31P NMR of pentose phosphate pathway block secondary to biochemical modulation.
    NMR in biomedicine, 1996, Volume: 9, Issue:3

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Magnetic Resonance Spectroscopy; Male; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred C3H; Pentose Phosphate Pathway; Phosphonoacetic Acid; Phosphorus; Teratogens

1996
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation.
    Anti-cancer drugs, 1996, Volume: 7, Issue:6

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Paclitaxel; Phosphonoacetic Acid; Remission Induction

1996
Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation.
    Cancer investigation, 1997, Volume: 15, Issue:2

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Disease Progression; Doxorubicin; Drug Synergism; Evaluation Studies as Topic; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Phosphorus Isotopes; Radiation-Sensitizing Agents

1997
Radiation enhancement by biochemical modulation and 5-fluorouracil.
    International journal of radiation oncology, biology, physics, 1997, Dec-01, Volume: 39, Issue:5

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Combined Modality Therapy; Fluorouracil; Mammary Neoplasms, Animal; Methylthioinosine; Mice; Radiation-Sensitizing Agents; Radiotherapy Dosage; Time Factors

1997
PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 108

    Topics: 6-Aminonicotinamide; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; beta Catenin; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Humans; Interleukin-6; Macrophages; MAP Kinase Signaling System; Methylthioinosine; STAT3 Transcription Factor; THP-1 Cells; Wnt Signaling Pathway

2018